CAS: 83207-58-3; (2R,3R,4S,5S,6R)-2-(((2Ar,3R,4S,5As,5Bs,7S,7Ar,9S,11Ar,12As)-4-Hydroxy-3-((2S,5R)-5-(2-Hydroxypropan-2-yl)-2-Methyltetrahydrofuran-2-yl)-2A,5A,8,8-Tetramethyl-9-(((2S,3R,4S,5R)-3,4,5-Trihydroxytetrahydro-2H-Pyran-2-yl)Oxy)Hexadecahydrocyclopenta[a]Cyclopr

合成参考文献

参考文献:10.1159/000121335
摘要:Xu XL, Chen XJ, Ji H, Li P, Bian YY, Yang D, Xu JD, Bian ZP, Zhang JN. Astragaloside IV improved intracellular calcium handling in hypoxia-reoxygenated cardiomyocytes via the sarcoplasmic reticulum Ca-ATPase. Pharmacology. 2008;81(4):325–32. doi: 10.1159/000121335.
参考文献:10.1177/1535370214532597
摘要:Wang L, Chi YF, Yuan ZT, Zhou WC, Yin PH, Zhang XM, Peng W, Cai H. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro. Exp Biol Med (Maywood). 2014 Oct;239(10):1310–24. doi: 10.1177/1535370214532597.
参考文献:10.1007/s10753-015-0272-4
摘要:Chen T, Wang R, Jiang W, Wang H, Xu A, Lu G, Ren Y, Xu Y, Song Y, Yong S, Ji H, Ma Z. Protective Effect of Astragaloside IV Against Paraquat-Induced Lung Injury in Mice by Suppressing Rho Signaling. Inflammation. 2016 Feb;39(1):483–92. doi: 10.1007/s10753-015-0272-4.
参考文献:10.1002/bmc.3941
摘要:Shao Y, Zhang W, Tong L, Huang J, Li D, Nie W, Zhu Y, Li Y, Lu T. Simultaneous determination of eight bioactive components of Qishen Yiqi dripping pills in rat plasma using UFLC-MS/MS and its application to a pharmacokinetic study. Biomed Chromatogr. 2017 Aug;31(8). doi: 10.1002/bmc.3941.
参考文献:10.1080/10715762.2017.1290233
摘要:Dong H, Guo H, Liang Y, Wang X, Niu Y. Astragaloside IV synergizes with ferulic acid to suppress hepatic stellate cells activation in vitro. Free Radic Res. 2017 Feb;51(2):167–78. doi: 10.1080/10715762.2017.1290233.